CELLECTIS - ANNUAL SHAREHOLDERS MEETING - June 28, 2022
VOTE RESULTS
Ordinary Resolutions
Nb | Resolution | Result | For | Against | Vote withhold | Total votes | Shares | Percentage of | Out of vote | Null | Quorum | |||
the share capital | voting | |||||||||||||
representedby | voting | |||||||||||||
represented by | rights | |||||||||||||
Votes | % | Votes | % | Votes | % | the votes cast | rights | |||||||
thevotes cast | ||||||||||||||
Approval of the annual financial statements for the financial year ended December 31, 2021
1 | ||||||||||||||||
1 | Carried | 35 525 535 | 99,91 % | 31 864 | 0,09 % | 76 147 | - | 35 557 399 | 30 600 674 | 67,238 % | 0 | 0 | 67,238 % | |||
Approval of | the consolidated | financial statements | for the financial year ended December 31, 2021 | |||||||||||||
2 | ||||||||||||||||
2 | Carried | 35 511 370 | 99,91 % | 32 029 | 0,09 % | 90 147 | - | 35 543 399 | 30 600 674 | 67,238 % | 0 | 0 | 67,238 % | |||
Appropriation | of results for | the financial year ended December 31, 2021 | ||||||||||||||
3 | ||||||||||||||||
3 | Carried | 35 519 285 | 99,90 % | 36 994 | 0,10 % | 77 267 | - | 35 556 279 | 30 600 674 | 67,238 % | 0 | 0 | 67,238 % | |||
Allocation of | losses carried | forward to the "share | premium" | account | ||||||||||||
4 | ||||||||||||||||
4 | Carried | 35 519 402 | 99,89 % | 37 477 | 0,11 % | 76 667 | - | 35 556 879 | 30 600 674 | 67,238 % | 0 | 0 | 67,238 % | |||
Determination | of the total | remuneration of the non-executive members of the Board of Directors | ||||||||||||||
5 | ||||||||||||||||
5 | Carried | 31 764 600 | 89,18 % | 3 852 491 | 10,82 % | 16 455 | - | 35 617 091 | 30 600 674 | 67,238 % | 0 | 0 | 67,238 % | |||
Ratification of the appointment of an Observer decided by the Board of Directors | ||||||||||||||||
6 | ||||||||||||||||
6 | Carried | 35 261 439 | 99,17 % | 295 772 | 0,83 % | 76 335 | - | 35 557 211 | 30 600 674 | 67,238 % | 0 | 0 | 67,238 % | |||
1/5
CELLECTIS - ANNUAL SHAREHOLDERS MEETING - June 28, 2022
VOTE RESULTS
Ordinary Resolutions
Nb | Resolution | Result | For | Against | Vote withhold | Total votes | Shares | Percentage of | Out of vote | Null | Quorum | |||
the share capital | voting | |||||||||||||
representedby | voting | |||||||||||||
represented by | rights | |||||||||||||
Votes | % | Votes | % | Votes | % | the votes cast | rights | |||||||
thevotes cast | ||||||||||||||
Appointment of a new director (Mr. Donald A. Bergstrom)
7 | ||||||||||||||
7 | Carried | 35 057 038 | 98,59 % | 500 363 | 1,41 % | 76 145 | - | 35 557 401 | 30 600 674 | 67,238 % | 0 | 0 | 67,238 % | |
Appointment | of a new Director Mr. Axel-Sven Malkomes | |||||||||||||
8 | ||||||||||||||
8 | Carried | 35 082 096 | 98,66 % | 474 695 | 1,34 % | 76 755 | - | 35 556 791 | 30 600 674 | 67,238 % | 0 | 0 | 67,238 % | |
Authorization | to the Board | of Directors to buy back shares of the Company | ||||||||||||
9 | ||||||||||||||
9 | Carried | 35 063 860 | 98,63 % | 487 983 | 1,37 % | 81 703 | - | 35 551 843 | 30 600 674 | 67,238 % | 0 | 0 | 67,238 % | |
2/5
CELLECTIS - ANNUAL SHAREHOLDERS MEETING - June 28, 2022
VOTE RESULTS
Extraordinary Resolutions
Nb | Resolution | Result | For | Against | Vote withhold | Total votes | Shares | Percentage of | Out of vote | Null | Quorum | |||
the share capital | voting | |||||||||||||
representedby | voting | |||||||||||||
represented by | rights | |||||||||||||
Votes | % | Votes | % | Votes | % | the votes cast | rights | |||||||
thevotes cast | ||||||||||||||
Authorization to be granted to the Board of Directors to reduce the share capital by cancelling shares under the authorization to buy back its own shares
10
10 | Carried | 35 515 847 | 99,88 % | 41 528 | 0,12 % | 76 171 | - | 35 557 375 | 30 600 674 | 67,238 % | 0 | 0 | 67,238 % |
Delegation of authority to be granted to the Board of Directors to increase the capital by issuing ordinary shares or any other securities with cancellation of shareholders' preferential subscription rights in favor of a category of persons meeting specified characteristics (investors with experience in the health or biotech sector)
11
11 | Carried | 34 658 582 | 97,47 % | 899 079 | 2,53 % | 75 885 | - | 35 557 661 | 30 600 674 | 67,238 % | 0 | 0 | 67,238 % | |
Delegation of authority to be granted to the Board of Directors to increase the capital by issuing ordinary shares or any other securities with cancellation of shareholders' preferential subscription rights in favor of a category of persons meeting specified characteristics (e.g. credit institution, investment services provider or member of an investment pool guaranteeing the completion of the issue in question), including, as the case may be, within the
12 framework of an equity financing program known as "At-the-market" or "ATM".
12 | Carried | 34 652 483 | 97,46 % | 903 976 | 2,54 % | 77 087 | - | 35 556 459 | 30 600 674 | 67,238 % | 0 | 0 | 67,238 % |
Delegation of authority to be granted to the Board of Directors to increase the share capital by issuing ordinary shares or any other securities, with cancellation of shareholders' preferential subscription rights in favor of a category of persons meeting specified characteristics (industrial companies, institutions or entities active in the health or biotechnology sector)
13
13 | Carried | 34 657 564 | 97,47 % | 899 097 | 2,53 % | 76 885 | - | 35 556 661 | 30 600 674 | 67,238 % | 0 | 0 | 67,238 % | |
Delegation of authority to be granted to the Board of Directors to increase the share capital by issuing ordinary shares or any other securities with cancellation of shareholders' preferential subscription rights in favor of a category of persons meeting specified characteristics in the framework of an equity or bond financing agreement
14
14 | Carried | 34 654 845 | 97,46 % | 901 651 | 2,54 % | 77 050 | - | 35 556 496 | 30 600 674 | 67,238 % | 0 | 0 | 67,238 % |
Delegation of authority to be granted to the Board of Directors to decide on the issuance of ordinary shares to be issued immediately or in the future by the Company, with cancellation of the shareholders' preferential subscription rights, to the benefit of a category of persons meeting specified characteristics within the framework of an equity financing program on the American Market known as "At-the-market" or "ATM".
15
15 | Carried | 34 656 035 | 97,47 % | 900 609 | 2,53 % | 76 902 | - | 35 556 644 | 30 600 674 | 67,238 % | 0 | 0 | 67,238 % |
3/5
CELLECTIS - ANNUAL SHAREHOLDERS MEETING - June 28, 2022
VOTE RESULTS
Extraordinary Resolutions
Nb | Resolution | Result | For | Against | Vote withhold | Total votes | Shares | Percentage of | Out of vote | Null | Quorum | |||
the share capital | voting | |||||||||||||
representedby | voting | |||||||||||||
represented by | rights | |||||||||||||
Votes | % | Votes | % | Votes | % | the votes cast | rights | |||||||
thevotes cast | ||||||||||||||
Delegation of authority to be granted to the Board of Directors to increase the share capital by issuing ordinary shares and/or any other securities, with the shareholders' preferential subscription rights maintained,
16
16 | Carried | 35 063 590 | 98,61 % | 493 056 | 1,39 % | 76 900 | - | 35 556 646 | 30 600 674 | 67,238 % | 0 | 0 | 67,238 % | ||
Delegation of authority to be granted to the Board of Directors to increase the share capital by issuing ordinary shares and/or any other securities, with cancellation of shareholders' pre-emptive subscription rights, by way of a | |||||||||||||||
17 | public offering (other than the offerings referred to in paragraph 1 of Article L. 411-2 of the French Monetary and Financial Code) | ||||||||||||||
17 | Carried | 34 650 068 | 97,45 % | 906 126 | 2,55 % | 77 352 | - | 35 556 194 | 30 600 674 | 67,238 % | 0 | 0 | 67,238 % | ||
Delegation of authority to be granted to the Board of Directors to increase the share capital by issuing ordinary shares and/or any other securities, with cancellation of the shareholders' preferential subscription rights in the | |||||||||||||||
18 | context of an offer referred to in paragraph 1° in of Article L. 411-2 of the French Monetary and Financial Code | ||||||||||||||
18 | Carried | 34 650 995 | 97,45 % | 905 651 | 2,55 % | 76 900 | - | 35 556 646 | 30 600 674 | 67,238 % | 0 | 0 | 67,238 % | ||
Delegation to the Board to increase the number of shares to be issued in the event of a capital increase with or without preferential subscription rights | |||||||||||||||
19 | |||||||||||||||
19 | Carried | 34 644 486 | 97,48 % | 897 381 | 2,52 % | 91 679 | - | 35 541 867 | 30 600 674 | 67,238 % | 0 | 0 | 67,238 % | ||
Overall limitations on the amount of issues made under the Erreur ! Source du renvoi introuvable. to Erreur ! Source du renvoi introuvable.s | |||||||||||||||
20 | |||||||||||||||
20 | Carried | 35 276 317 | 99,21 % | 280 058 | 0,79 % | 77 171 | - | 35 556 375 | 30 600 674 | 67,238 % | 0 | 0 | 67,238 % | ||
Delegation of authority granted to the Board of | Directors to | increase the capital by incorporation of premiums, reserves, profits or other | |||||||||||||
21 | |||||||||||||||
21 | Carried | 35 060 503 | 98,61 % | 495 362 | 1,39 % | 77 681 | - | 35 555 865 | 30 600 674 | 67,238 % | 0 | 0 | 67,238 % | ||
4/5
CELLECTIS - ANNUAL SHAREHOLDERS MEETING - June 28, 2022
VOTE RESULTS
Extraordinary Resolutions
Nb | Resolution | Result | For | Against | Vote withhold | Total votes | Shares | Percentage of | Out of vote | Null | Quorum | |||
the share capital | voting | |||||||||||||
representedby | voting | |||||||||||||
represented by | rights | |||||||||||||
Votes | % | Votes | % | Votes | % | the votes cast | rights | |||||||
thevotes cast | ||||||||||||||
Authorization to the Board of Directors to grant options to subscribe for or purchase shares of the Company
22
22 | Carried | 34 373 630 | 96,51 % | 1 242 715 | 3,49 % | 17 201 | - | 35 616 345 | 30 600 674 | 67,238 % | 0 | 0 | 67,238 % | |
Authorization | to the Board | of Directors to proceed | with the | free allocation of existing and/or new ordinary shares | ||||||||||
23 | ||||||||||||||
23 | Carried | 34 811 605 | 97,74 % | 804 364 | 2,26 % | 17 577 | - | 35 615 969 | 30 600 674 | 67,238 % | 0 | 0 | 67,238 % | |
Delegation of authority to be granted to the Board of Directors to allocate share subscription warrants giving the right to subscribe to ordinary shares of the Company - suppression of the preferential subscription right in favor | ||||||||||||||
24 | of a category of persons meeting specific characteristics | |||||||||||||
24 | Rejected | 16 002 881 | 60,12 % | 10 617 406 | 39,88 % | 9 013 259 | - | 26 620 287 | 30 600 674 | 67,238 % | 0 | 0 | 67,238 % | |
Overall limits | on the amount | of issues made under the above issues made under the Erreur ! Source du renvoi introuvable. and the Erreur ! Source du renvoi introuvable. above | ||||||||||||
25 | ||||||||||||||
25 | Carried | 35 486 528 | 99,84 % | 55 867 | 0,16 % | 91 151 | - | 35 542 395 | 30 600 674 | 67,238 % | 0 | 0 | 67,238 % | |
Delegation | to the Board of Directors to proceed with an increase in the share capital, the subscription of which would be reserved for the members of a company savings plan established pursuant to Articles L. 3332-1 et seq. | |||||||||||||
26 | of the Labor Code | |||||||||||||
26 | Rejected | 6 610 718 | 18,57 % | 28 994 859 | 81,43 % | 27 969 | - | 35 605 577 | 30 600 674 | 67,238 % | 0 | 0 | 67,238 % | |
5/5
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Cellectis SA published this content on 28 June 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 June 2022 20:56:04 UTC.